𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and Immunogenicity of a Yeast-Derived Recombinant Hepatitis B Vaccine in Bulgarian Newborns

✍ Scribed by M. Kojouharova; P. Teoharov; T. Bahtchevanova; I. Maeva; A. Eginlian; M. Deneva

Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
81 KB
Volume
29
Category
Article
ISSN
0300-8126

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.

Recombinant-yeast-derived hepatitis b va
Recombinant-yeast-derived hepatitis b vaccine in healthy adults: Safety and two-year immunogenicity of early investigative lots of vaccine
✍ Lynn Butterly; Eloise Watkins; Jules L. Dienstag πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 554 KB

We tested the safety and long-term immunogenicity of two of the early investigative lots of a recombinant-yeast-derived hepatitis B vaccine in immunocompetent adults. Three 10-micrograms doses of recombinant hepatitis B vaccine (Merck Sharp & Dohme Research Laboratories, West Point, PA) were adminis

Immunogenicity of a yeast-recombinant he
Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk children
✍ M. G. Rumi; R. Romeo; M. Bortolini; A. Gringeri; A. R. Zanett; P. M. Mannucci; M πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 391 KB

Horizontal transmission of hepatitis B virus (HBV) from illicit drug users to their contacts, including young children, can be prevented by active immunization against HBV. Yeast-recombinant hepatitis B vaccines are now available for this purpose, but their potential efficacy in such high-risk conta

Comparative evaluation of the immunogeni
Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants
✍ Subrat K. Panda; Rajagopal Ramesh; Kanury V. S. Rao; Asha Gupta; Arie J. Zuckerm πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 661 KB

## Abstract The immunogenicity of plasma‐derived (HB Vax, MSD) and recombinant hepatitis B virus (Engerix B, SKF) vaccines was evaluated in infants born to hepatitis B virus carrier mothers. The vaccination was carried out at 1 day, 1 month, and 6 months of age using 10 ΞΌg of the vaccine given intr